LifeVest Wearable Defibrillator
Zoll Manufacturing Corporation · Decision date Sep 29, 2026
What did the FDA decide?
The FDA recorded decision OK30 on 2026-09-29 for PMA supplement P010030/S203, submitted by Zoll Manufacturing Corporation for the LifeVest® Wearable Defibrillator under product code MVK in the Cardiovascular specialty. The supplement is a 30-Day Notice with the recorded reason Process Change - Manufacturer/Sterilizer/Packager/Supplier, and the stated scope is implementation of an alternate finishing process.
This entry concerns a manufacturing process change to an existing approved device rather than a new approval of the LifeVest system, and the source does not identify which component or finishing step is affected. The source also gives no detail on the alternate process, the review basis for OK30, or any conditions attached to the notice, so those points remain unknown from this record.
FDA approval order statement
implementation of an alternate finishing process
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 29, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P010030/S203
- Regulatory pathway
- PMA supplement
- Applicant
- Zoll Manufacturing Corporation
- Product code
- MVK
- Decision code
- OK30
- Decision date
- Sep 29, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Wearable automated external defibrillator.
- Applicant
- Zoll Manufacturing Corporation
- Product code
- MVK
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P010030. Subsequent supplements may change the device or its indications.
FDA decision timeline
P010030 · Original PMA
WEARABLE CARDIOVERTER DEFIBRILLATOR (WCD) 2000 LIFEVEST
P010030/S203 received
Application receipt date recorded by FDA.
P010030/S201 · Related supplement
LifeVest Wearable Defibrillator
P010030/S203 · FDA decision
30-Day Notice
P010030/S204 · Related supplement
LifeVest Wearable Defibrillator
P010030/S205 · Related supplement
LifeVest Wearable Defibrillator
Timeline entries are records held by MedtechLedger for P010030. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P010030
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Zoll Manufacturing Corporation | PMA approval | Dec 18, 2001 | FDA | |
LifeVest Wearable DefibrillatorP010030/S201 | Zoll Manufacturing Corporation | PMA supplement | Sep 9, 2026 | FDA |
LifeVest Wearable DefibrillatorP010030/S204 | Zoll Manufacturing Corporation | PMA supplement | Oct 5, 2026 | FDA |
LifeVest Wearable DefibrillatorP010030/S205 | Zoll Manufacturing Corporation | PMA supplement | Oct 6, 2026 | FDA |
Explore the linked device profile
Other records with product code MVK
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Kestra Medical Technologies, Inc. | PMA supplement | Nov 4, 2026 | FDA | |
| Kestra Medical Technologies, Inc. | PMA supplement | Sep 28, 2026 | FDA | |
| Kestra Medical Technologies, Inc. | PMA approval | Jul 27, 2021 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Zoll Manufacturing Corporation
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 121 Gamma Dr., Pittsburgh, PA, 15238
Sources and methodology
- Original FDA record: P010030/S203
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



